Men with sex addiction may have raised levels of the hormonal agent oxytocin.
Cognitive behavioral therapy may help in reducing hypersexual habits and oxytocin levels.
Guy with hypersexual condition may have greater levels of oxytocin in their blood than men without the condition, according to a small study published in the Endocrine Societys Journal of Clinical Endocrinology & & Metabolism
. Hypersexual disorder includes extreme, persistent sexual behaviors connected to different mood states, with an impulsivity element and skilled loss of control.
Oxytocin is a hormone produced by the hypothalamus and secreted by the pituitary gland. It plays an essential function in sexual behavior, and unusual levels of the hormonal agent might contribute to hypersexual disorder.
” We discovered that males with compulsive sexual habits condition (CSBD) had higher oxytocin levels compared with healthy males,” stated Andreas Chatzittofis, M.D., Ph.D., of the University of Cyprus Medical School in Nicosia, Cyprus and Umeå University in Umeå, Sweden. “Cognitive behavioral treatment caused a reduction in both hypersexual behavior and oxytocin levels.”
The researchers analyzed the blood samples of 64 men with hypersexual disorder and 38 healthy males and discovered the hypersexual guys had greater levels of oxytocin in their blood. Thirty males with hypersexual condition went through a cognitive behavioral treatment program and saw a considerable reduction in their oxytocin levels after treatment.
” Oxytocin plays a crucial function in sex addiction and may be a prospective drug target for future medicinal treatment,” Chatzittofis stated.
Recommendation:” High Plasma Oxytocin Levels in Men With Hypersexual Disorder” by John Flanagan, Andreas Chatzittofis, Adrian Desai E Boström, Jonas Hallberg, Katarina Görts Öberg, Stefan Arver and Jussi Jokinen, 2 February 2022, The Journal of Clinical Endocrinology & & Metabolism.DOI: 10.1210/ clinem/dgac015.
Other authors of the research study consist of: John Flanagan, Jonas Hallberg, Katarina Görts Öberg and Stefan Arver of Karolinska University Hospital in Solna, Sweden; Adrian Desai E. Boström of University of Cyprus in Nicosia, Cyprus and Umeå University; and Jussi Jokinen of Umeå University and Karolinska Institutet in Stockholm, Sweden.
The research study received funding from the Swedish Research Council, the Stockholm Regional Council and the Region Västerbotten.